Publication | Open Access
The effect of emicizumab prophylaxis on health‐related outcomes in persons with haemophilia A with inhibitors: HAVEN 1 Study
91
Citations
34
References
2018
Year
In PwHA with inhibitors, emicizumab prophylaxis was associated with substantial and meaningful improvements in health-related outcomes.
| Year | Citations | |
|---|---|---|
Page 1
Page 1